Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Men with prostate cancer get stronger bones from playing football

Men with prostate cancer run the risk of brittle bones as a side-effect of their treatment. But one hour's football training a few times a week counters many of the negative effects of the treatment, according to University of Copenhagen scientists.

23 Nov 2015

NICE recommends Xofigo (radium-223 dichloride) for patients with advanced prostate cancer

The National Institute for Health and Care Excellence today issued its Final Appraisal Determination (FAD) recommending Xofigo (radium-223 dichloride) for use on the NHS in England as an option for treating adult men, with hormone-relapsed prostate cancer, symptomatic bone metastases and no known visceral metastases, who have received previous docetaxel therapy.

20 Nov 2015

U of A researcher's work on prostate cancer metastasis earns top award

A University of Alberta researcher's work to identify patients at greatest risk of prostate cancer cells spreading to another part of the body has earned a top award at a showcase of the world's best up-and-coming research talent.

20 Nov 2015

VolitionRx's NuQ blood tests accurately detect more than 90% of lung cancer cases

VolitionRx Limited today announced interim data demonstrating its NuQ blood tests have accurately detected more than 90% of lung cancer cases in a study of 73 patients.

19 Nov 2015

Living with lung cancer: an interview with Aoife McNamara

Understanding how lung cancer affects patients from a social perspective is vital. People living with lung cancer, lung cancer survivors and carers are impacted by lung cancer in different ways.

18 Nov 2015

Scientists identify mechanism that may help prostate cancer cells escape effects of cancer drugs

Advanced prostate cancer is a disease notoriously resistant to treatment. New research by scientists at Fred Hutchinson Cancer Research Center and the University of California, San Francisco sheds light on a new mode of drug resistance to emerging therapies in metastatic prostate cancer.

18 Nov 2015

Exercise, healthy lifestyle habits may cut prostate cancer risk by up to 68%

A study that tracked tens of thousands of midlife and older men for more than 20 years has found that vigorous exercise and other healthy lifestyle habits may cut their chances of developing a lethal type of prostate cancer by up to 68 percent.

18 Nov 2015

Two studies find decline in PSA screening and prostate cancer incidence

Two studies in the November 17 issue of JAMA examine the change in prostate-specific antigen (PSA) screening and prostate cancer incidence before and after the 2012 U.S. Preventive Services Task Force (USPSTF) screening recommendations.

18 Nov 2015

Bone protein can inhibit prostate cancer metastasis to bone

Scientists from Lawrence Livermore National Laboratory in collaboration with researchers from University of California campuses at Merced and Davis have found that a secreted protein predominantly expressed in bone inhibits prostate cancer metastasis to bone.

18 Nov 2015

MicroRNA reduces tumor growth, increases cell death in castration-resistant prostate cancer

Researchers at the UC Davis Comprehensive Cancer Center have shown that the microRNA, miR-124, reduced tumor growth and increased cell death in castration-resistant prostate cancer.

17 Nov 2015

PSA screening for prostate cancer drops significantly in middle-aged men

PSA testing has dropped significantly in middle-aged men after a 2012 recommendation that all men should not be routinely screened for prostate cancer, according to a new study published in the Journal of the American Medical Association.

17 Nov 2015

Study may lead to development of highly accurate screening test for early-stage ovarian cancer

Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.

17 Nov 2015

IASLC commends FDA's decision to grant accelerated approval for new lung cancer therapy

The International Association for the Study of Lung Cancer commends the U.S. Food and Drug Administration's (FDA) decision to grant accelerated approval for osimertinib (Tagrisso), an oral medication for advanced non-small cell lung cancer (NSCLC) patients with a specific epidermal growth factor receptor (EGFR) mutation (T790M) and following progression after previous EGFR inhibitor therapies.

17 Nov 2015

U of I scientists show that tomato component reduces growth of prostate tumors in animal models

Years of research in University of Illinois scientist John Erdman's laboratory have demonstrated that lycopene, the bioactive red pigment found in tomatoes, reduces growth of prostate tumors in a variety of animal models. Until now, though, he did not have a way to trace lycopene's metabolism in the human body.

13 Nov 2015

Prostate cancer market to expand at CAGR of 9.5% to $13.6 billion by 2021

Analysis from business intelligence provider GBI Research - Prostate Cancer Market to 2021 - Increasing Disease Prevalence to be a Key Driver of Market Growth - says that the prostate cancer market will expand at a rapid Compound Annual Growth Rate (CAGR) of 9.5% from $7.6 billion in 2014 to $13.6 billion by 2021.

12 Nov 2015

New antenna-like device makes breast cancer surgery easier for surgeons

Breast cancer surgeons routinely face a dilemma: how to find tumors they cannot feel. Before going into the operating room they must use some method to locate them. Currently, the method they use requires a radiologist to insert a device into the woman's breast.

12 Nov 2015

CWRU awarded two NIH grants to create pathology image informatics platform

Case Western Reserve University researchers have been awarded two grants totaling $3.16 million from the National Institutes of Health to create analytic software for managing, annotating, sharing and analyzing digital pathology imaging data.

12 Nov 2015

Biocept receives European patent covering antibody usage in capture of rare cells

Biocept, Inc., a molecular diagnostics company commercializing and developing liquid biopsies to improve the diagnosis and treatment of cancer, announces that the European Patent Office has awarded the patent, "DEVICES AND METHODS OF CELL CAPTURE AND ANALYSIS," as announced in the European Bulletin dated November 11, 2015.

11 Nov 2015

HIFU Prostate Services announces groundbreaking partnerships to offer prostate cancer treatments

HIFU Prostate Services, LLC, a leading provider of minimally-invasive prostate cancer treatment using High Intensity Focused Ultrasound ("HIFU"), announces groundbreaking partnerships with Michael J. Lazar, MD in Santa Rosa, Calif. and John H. Jurige, MD in Louisville, Ky., to offer HIFU treatments for prostate cancer.

9 Nov 2015

New protein supplement lowers cholesterol, prevents osteoporosis

Scientists developed a supplement to maintain optimal health that contributes to the growth and development of children and adolescents. It also prevents osteoporosis and certain cancers such as breast and prostate.

5 Nov 2015

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Men with prostate cancer get stronger bones from playing football

NICE recommends Xofigo (radium-223 dichloride) for patients with advanced prostate cancer

U of A researcher's work on prostate cancer metastasis earns top award

VolitionRx's NuQ blood tests accurately detect more than 90% of lung cancer cases

Living with lung cancer: an interview with Aoife McNamara

Scientists identify mechanism that may help prostate cancer cells escape effects of cancer drugs

Exercise, healthy lifestyle habits may cut prostate cancer risk by up to 68%

Two studies find decline in PSA screening and prostate cancer incidence

Bone protein can inhibit prostate cancer metastasis to bone

MicroRNA reduces tumor growth, increases cell death in castration-resistant prostate cancer

PSA screening for prostate cancer drops significantly in middle-aged men

Study may lead to development of highly accurate screening test for early-stage ovarian cancer

IASLC commends FDA's decision to grant accelerated approval for new lung cancer therapy

U of I scientists show that tomato component reduces growth of prostate tumors in animal models

Prostate cancer market to expand at CAGR of 9.5% to $13.6 billion by 2021

New antenna-like device makes breast cancer surgery easier for surgeons

CWRU awarded two NIH grants to create pathology image informatics platform

Biocept receives European patent covering antibody usage in capture of rare cells

HIFU Prostate Services announces groundbreaking partnerships to offer prostate cancer treatments

New protein supplement lowers cholesterol, prevents osteoporosis

What to know about prostate cancer eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in